Sunburn Clinical Trial
Official title:
Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics
Verified date | November 2023 |
Source | Sun Protection Foundation |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to assess how human skin reacts and how sunscreens and sun protection fabrics protect in natural sunlight compared to their labeled claims, indoor testing methods (existing or modified) and instructions.
Status | Enrolling by invitation |
Enrollment | 200 |
Est. completion date | January 2040 |
Est. primary completion date | January 2040 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 15 Years to 90 Years |
Eligibility | Inclusion Criteria: 1. Fitzpatrick Type I, II, III, IV or V type skin. 2. Must be able to be exposed to natural sunlight for up to 4 hours in a prone position 3. Able to read, write, speak and understand the English language. 4. Has personally read, signed, and dated the Informed Consent Form (including HIPAA disclosure) and Photograph Release 5. Generally in good health based on medical history reported by the subject 6. Healthy male or female subjects with no history or evidence of clinically relevant medical disorder, as determined from a brief medical history interview. 7. Willing and able to follow the study instructions, including: - Remain outdoors exposed to the sun or in the laboratory for up to 4 hours on Day 1 during the study with exposed skin on back protected by sunscreens and fabrics - Apply the specific sunscreens and fabrics to designated sites on the back and lie motionless. - No visual signs of recent sun exposure to the back. - No sunscreens or lotions recently used on the back. - Attend scheduled visits and intend to successfully complete the study - Stay out of the sun or stay indoors from sun exposure until after observation on Day 2. - Women are discouraged from using a bra that applies pressure to the skin site areas that may make it difficult to assess erythema or PPD on Day 2. - Refrain from using other sunscreen products or tanning bed use during the duration of the study. Exclusion Criteria: 1. Individuals with known allergies or sensitivities to sunscreens or any ingredient contained in the test products or common topical skincare products, including adhesives. 2. Perceptible erythema, PPD on the back as determined by the PI or designee. 3. Women known to be pregnant or nursing. 4. Individuals with any disease or condition of the skin (e.g., active [i.e. flaring] eczema or psoriasis, skin cancer, atypical nevus, polymorphic light eruption (PMLE), porphyria, systemic lupus erythematous (SLE), xeroderma pigmentosa (XP)) that could interfere with the study or increase risk to the subject. 5. Individuals with self-reported UNCONTROLLED metabolic conditions, such as diabetes, hypertension, hyper/hypothyroidism, hypercholesterolemia 6. Subjects who are taking medication for chronic conditions that may make a subject more sun sensitive (e.g., Tetracyclines, antifungals, certain diuretics, etc.) 7. Skin diseases on tested sites (e.g., photosensitivity disorders, etc.), which may influence the outcome of the study 8. An individual who has any condition which in the PI's judgment makes the candidate an inappropriate subject for study participation 9. Individuals with a condition or situation which, in the PI's opinion, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study 10. Individual viewed by the PI as not being able to complete the study |
Country | Name | City | State |
---|---|---|---|
Chile | Sun Protection Foundation | Santiago | |
Peru | Sun Protection Foundation | Arequipa | |
United States | Sun Protection Foundation | San Diego | California |
United States | Sun Protection Foundation | Seattle | Washington |
United States | Sun Protection Foundation | Waimea | Hawaii |
Lead Sponsor | Collaborator |
---|---|
Sun Protection Foundation |
United States, Chile, Peru,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Erythema | • Erythema was assessed using a scale of 0 = no perceptible sun induced skin reaction, 1 = perceptible erythema but spotty or without clear borders (<1 MED); 2 = minimal erythema over the entire site with distinct borders (1 MED reaction); 3 = more than minimal; 4 = a serious erythema; and 5 = edema and blisters.
Determination made by blinded evaluator on-site or using chroma-meter and photographs. |
16-24 hours post exposure to natural sunlight | |
Primary | Persistent Pigment Darkening (PPD) | Persistent Pigment Darkening was assessed using a scale of 0 = no perceptible sun induced skin reaction, 1 = perceptible but spotty or without clear borders (<1 MPPDD); 2 = minimal PPD over the entire site with distinct borders (1 MPPDD reaction); 3 = more than minimal; 4 = a serious erythema; and 5 = edema and blisters
Determination made by blinded evaluator on-site or using chroma-meter and photographs. |
16-24 hours post exposure to natural sunlight |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00206882 -
The Sun Protection Effect and Efficacy in Treatment of Sunburn Using Topical Corticosteroids.
|
N/A | |
Completed |
NCT05767008 -
Water Immersion Studies of a Long-wear Sunscreen to Improve Protection Against Ultraviolet Radiation
|
N/A | |
Completed |
NCT00441051 -
Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn
|
Phase 3 | |
Completed |
NCT01873430 -
The Sun Protective Effect of Melatonin
|
Phase 1 | |
Completed |
NCT00326274 -
Clinical Safety Trial of Long-Term Intermittent Use of Helioblock® SX Cream
|
Phase 3 | |
Completed |
NCT03199573 -
Hats on Head Start: A A Survey of Sun Protection Behaviors in Head Start and Other Early Childhood Education Programs
|
N/A | |
Terminated |
NCT03332524 -
Clinical Trial of the Safety and Efficacy of SP160412 in the Temporary Relief of Mild to Moderate Sunburn
|
Phase 2 | |
Completed |
NCT03752736 -
Sun Safety Skills for Elementary School Students
|
N/A | |
Completed |
NCT05260359 -
Dermal Irritation, Sensitization and Cumulative Irritation Potential of 6% Bemotrizinol
|
Phase 2 | |
Completed |
NCT01021787 -
Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream
|
Phase 4 | |
Completed |
NCT03607578 -
Test of Interventions to Prevent Skin Cancer Among Danes on Vacation in High UV Index Sunny Destinations
|
N/A | |
Completed |
NCT03489356 -
Project Options - The ABC Method
|
N/A | |
Not yet recruiting |
NCT01237925 -
Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Gel) in the Relief of Sunburn Related Symptoms
|
Phase 3 | |
Not yet recruiting |
NCT01085851 -
Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Lotion) in the Relief of Sunburn Related Symptoms
|
Phase 3 |